The Health Welfare Of Patients - amazonia.fiocruz.br

The Health Welfare Of Patients The Health Welfare Of Patients

Navigation menu

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page. The datasets used or analyzed in the current study are available from the corresponding author upon reasonable request.

The Health Welfare Of Patients

Objectives: This study aimed to measure the induction level of drug welfare in Chinese patients with chronic diseases using a bivariate Theil index. Design: The bivariate Theil-T index was used to hierarchically decompose the relevant survey data, and the contribution rate of the intragroup gap and the intergroup gap to the total gap was investigated to better understand the current drug welfare induction level of Chinese patients with chronic diseases. Participants: Survey data was from patients with chronic diseases in 20 hospitals in four provinces.

The Health Welfare Of Patients

Primary and secondary outcome measures: Data was collected through a questionnaire designed by the research team after expert consultation. Using the variables represented by the index system to decompose the Theil index from the two dimensions of the region and urban and rural areas.

SPSS Results: The overall level The Health Welfare Of Patients drug welfare induction in Chinese patients with chronic diseases had a high degree of equalization. The overall Theil index was 0. Conclusions: To improve the drug welfare equalization induction level of patients with chronic diseases in China, the government should start from western rural Haelth, and policy should target the provinces that were in a disadvantaged position within the region to promote the equalization of drug welfare induction level for patients with chronic diseases in China.

With the change of the human disease spectrum, chronic diseases currently account for the majority of global morbidity, and mortality 12.

Associated Data

It is expected that bychronic non-communicable diseases chronic diseases will become the leading cause of death and disability in humans 34 and the most crucial disease burden in China. Chronic diseases have brought many challenges and burdens to patients and the health system.

Whether the drug needed for treatment is obtained and affordable is the most significant way to effectively control the incidence and mortality of chronic diseases. Chronic diseases, also known as non-communicable diseases NCDSare ongoing and often incurable diseases or conditions that require ongoing medical care and affect a person's daily life 56. Cardiovascular disease, arthritis, and diabetes are common chronic diseases. Older people with arthritis found that they have trouble with their normal activities 9 Diabetes is the leading cause of kidney failure, lower-limb amputation not due to injury, and new cases of blindness among adults The disease characteristics of chronic diseases determine that patients with chronic diseases need to take drugs for a The Health Welfare Of Patients time, and the cost of medicines accounts for the vast majority of medical expenses.]

One thought on “The Health Welfare Of Patients

Add comment

Your e-mail won't be published. Mandatory fields *